Shots:

• Medtronic has initiated site recruitment for the Transforaminal Lumbar Interbody Fusion (TLIF) clinical study to enroll up to 50 sites with over 1-000 patients. The expanded indication to use Infuse posterior spine procedures provide patients a powerful option in a spine surgeon’s armamentarium
• Additionally- in 2017- Medtronic got approval to evaluate Infuse Bone Graft in Posterolateral Fusion (PLF) and is working with the FDA to incorporate safety & efficacy data for indication expansion in PLF
• Medtronic continues to invest in the expansion of its Infuse Bone Graft for multiple indications. Infuse Bone Graft is an approved product for certain spine- oral-maxillofacial and orthopedic trauma surgeries and is being marketed since 2002

Click here to­ read full press release/ article | Ref: Medtronic | Image: Medtronic